Sector revisions Gedeon Richter LUXEMBOURG S.E.

Stocks

End-of-day quote LUXEMBOURG S.E. 02/10/2026			5-day change	1st Jan Change
38.00 ^USD	0.00%		-2.56%	+25.83%

18/09	EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug	MT
11/08	Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	MERCK & CO., INC.							25
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							23
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							26
	NOVO NORDISK A/S							23
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	BRISTOL-MYERS SQUIBB COMPANY							24
	MCKESSON CORPORATION							14
	SANOFI							24
	GSK PLC							21
	MODERNA, INC.							18
	REGENERON PHARMACEUTICALS, INC.							26
	MERCK KGAA							14
	Average							23
	Weighted average by Cap.							25